In this study, we found a prevalence of triple-SN-MG patients of 8.6%, which is slightly lower than that reported in previous studies.2, 8The MuSK-Abs MG and AChR-Abs MG subgroups accounted for 5.4% and 86% of the sample, respectively. The gene discussed is MUSK; the disease is myasthenia gravis.